Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Pharmacokinetic profile of ciclosporin derivative IMM-125

Nov. 18, 1997

FACET study demonstrates improved asthma control with Pulmicort and Oxis

Nov. 17, 1997

Novartis claims new antiasthmatic agents

Nov. 17, 1997

Pfizer describes new PDE IV inhibitor for asthma

Nov. 14, 1997

First interim phase III safety results reported for OxSODrol

Nov. 14, 1997

Pharmacokinetics, peripheral antihistaminic and central effects of rupatadine in humans

Nov. 13, 1997

New 5-LO inhibitors from Meiji Milk

Nov. 13, 1997

PDE IV inhibitor from Almirall does not stimulate gastric acid secretion in rats

Nov. 12, 1997

Dura submits NDA for Albuterol Spiros

Nov. 12, 1997

Zeneca selects new HLE inhibitor for clinical development

Nov. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...